Blood test may predict who benefits from targeted radiation therapy

NCT ID NCT06876532

Recruiting now Knowledge-focused Sponsor: Institut Claudius Regaud Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 14, 2026 · Updated 2 times

Summary

This study looks at whether an inflammation-based score (using CRP and albumin levels) can predict how well patients with advanced intestinal neuroendocrine tumors respond to Lu-177 oxodotreotide therapy. Researchers will follow 150 patients for 36 months, collecting blood samples and imaging data. The goal is to see if a simple, non-invasive test can help identify who is most likely to benefit from this treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Lu-177 oxodotreotide (a radioactive drug given as standard treatment)
What this could lead to: If successful, this could give doctors a simple blood test to predict which patients will respond to Lu-177 therapy, helping personalize treatment decisions.
What could go wrong: This is an observational study, not a treatment trial. The inflammation score is experimental and may not prove accurate enough for routine use.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INTESTINAL NEUROENDOCRINE TUMOR are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

intestinal neuroendocrine neoplasm intestinal neuroendocrine tumor G1

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

INTESTINAL NEUROENDOCRINE TUMOR

Contacts and locations

Locations

CHU Hôtel Dieu
RECRUITING

Nantes, France
CHU de Bordeaux
RECRUITING

Bordeaux, France
CHU de Lille
RECRUITING

Lille, France
CHU de Lyon
RECRUITING

Lyon, France
CHU de Poitiers
RECRUITING

Poitiers, France
Centre François Baclesse
RECRUITING

Caen, France
Hôpital La Timone
RECRUITING

Marseille, France
IUCT-O
RECRUITING

Toulouse, France
Institut de Cancérologie de Montpellier
RECRUITING

Montpellier, France
Institut de Cancérologie de l'Ouest
NOT_YET_RECRUITING

Angers, 49055, France